FindTrial
Sign In

Efficacy and Safety of Platelet rich plasma v/s Prolotherapy in the Management of Rotator cuff tendinosis.

Comparison of Platelet Rich Plasma v/s Prolotherapy in the Management Of Rotator Cuff Tendinosis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042385
Enrollment
Unknown
Registered
2022-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M678- Other specified disorders of synovium and tendon

Interventions

Intervention1: Platelet rich plasma: PRP Preparation: Whole blood will be withdrawn from the patients just prior to procedure into 2 citrate tubes. A standardized centrifugation based manual PRP metho

Sponsors

AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Failure to conservative treatment for 3 months. 2. Age over 18 years and less than 75 years of age.

Exclusion criteria

Exclusion criteria: 1. Underwent previous Intra-articular injection/invasive procedure. 2. Congenital or acquired platelet dysfunction. 3. Uncontrolled Diabetes Mellitus. 4. Non-consenting patient. 5. MRI contraindications

Design outcomes

Primary

MeasureTime frame
Outcome measures will be assessed using VAS score to see patient improvement and QuickDash Score to see change in disabilityTimepoint: At baseline pre-treatment and at 1, 3, 6 and 12 weeks after the injection—

Secondary

MeasureTime frame
Safety of both the tratmentTimepoint: At each visit(1, 3, 6 and 12 weeks after the injection)—

Countries

India

Contacts

Public ContactAnkit Singh

AIIMS, Jodhpur.

pushpinderkhera@gmail.com8003996914

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026